Pharmaids Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE117D01018
  • NSEID:
  • BSEID: 524572
INR
34.00
-1.03 (-2.94%)
BSENSE

Aug 11, 03:30 PM

BSE+NSE Vol: 19.2 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 799751,
    "name": "Pharmaids Pharma",
    "stock_name": "Pharmaids Pharma",
    "full_name": "Pharmaids Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/pharmaids-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "34.00",
    "chg": -1.03,
    "chgp": "-2.94%",
    "dir": -1,
    "prev_price": "35.03",
    "mcapval": "125.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524572,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE117D01018",
    "curr_date": "Aug 11, 03:30 PM",
    "curr_time": "06:04 AM",
    "last_traded_at": "Aug 11, 03:30 PM IST",
    "bse_nse_vol": "19.2 k",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/pharmaids-pharma-799751-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-4145072",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/PharmaidsPharma_mojoScore_4145072.png",
        "date": "2026-08-10 10:10:47",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 10 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "When is the next results date for Pharmaids Pharmaceuticals Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-pharmaids-pharmaceuticals-ltd-4142385",
        "imagepath": "",
        "date": "2026-08-07 23:19:59",
        "description": "The next results date for Pharmaids Pharmaceuticals Ltd is scheduled for 12 August 2026...."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-4128545",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/PharmaidsPharma_mojoScore_4128545.png",
        "date": "2026-07-30 10:10:29",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 July 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-4107914",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/PharmaidsPharma_mojoScore_4107914.png",
        "date": "2026-07-19 10:10:27",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-4093425",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/PharmaidsPharma_mojoScore_4093425.png",
        "date": "2026-07-08 10:10:56",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-4074934",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/PharmaidsPharma_mojoScore_4074934.png",
        "date": "2026-06-27 10:10:34",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 27 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-4055829",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/PharmaidsPharma_mojoScore_4055829.png",
        "date": "2026-06-16 10:11:10",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 June 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Declines 8.97%: Key Financial and Market Pressures This Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pharmaids-pharmaceuticals-declines-897-key-financial-and-market-pressures-this-week-4052218",
        "imagepath": "",
        "date": "2026-06-13 17:08:31",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jun 01:</strong> Stock hits 52-week low at Rs.25.6 amid sharp decline</p>\n                    <p><strong>Jun 02:</strong> Q4 FY26 results reveal mounting losses despite revenue growth</p>\n                    <p><strong>Jun 05:</strong> Week closes at Rs.27.62, down 8.97% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.30.34</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.27.62</div><div class=\"stat-change negative\">-8.97%</div></div>\n                    <div class=\"sta..."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-4033580",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/PharmaidsPharma_mojoScore_4033580.png",
        "date": "2026-06-03 10:10:33",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 03 June 2026, providing investors with the latest insights into its performance and outlook."
      }
    ],
    "total": 130,
    "sid": "799751",
    "stock_news_url": "https://www.marketsmojo.com/news/pharmaids-pharmaceuticals-799751"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended 30Th June 2026.",
      "datetime": "06-Aug-2026",
      "details": "",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Jul-2026",
      "details": "Certificate under Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations 2018 for the quarter ended June 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "30-Jun-2026",
      "details": "Appointment of M/s. V Mahendra & Associates as the Internal Auditors of the Company for carrying out the Internal Audit for the financial year 2026-27.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(12 Aug 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended 30Th June 2026.

06-Aug-2026 | Source : BSE

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

07-Jul-2026 | Source : BSE

Certificate under Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations 2018 for the quarter ended June 30 2026.

Announcement under Regulation 30 (LODR)-Change in Management

30-Jun-2026 | Source : BSE

Appointment of M/s. V Mahendra & Associates as the Internal Auditors of the Company for carrying out the Internal Audit for the financial year 2026-27.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

(12 Aug 2026)

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available